Theriva Biologics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2025
Total Assets: $38.2M
Liabilities Breakdown FY2025
Total Liabilities: $22.9M
Asset Breakdown
Total Assets: $38.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $13.1M | 34.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $222.0K | 0.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $19.6M | 51.3% |
| Other Assets | $5.3M | 14.0% |
Liabilities Breakdown
Total Liabilities: $22.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.0M | 4.4% |
| Long-Term Debt | $1.7M | 7.3% |
| Other Liabilities | $20.2M | 88.3% |